Navigation Links
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
Date:11/14/2013

CRANBURY, N.J., Nov. 14, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its first quarter ended September 30, 2013. 

Recent Highlights
Bremelanotide development for Female Sexual Dysfunction (FSD):

  • Successful completion of device bioequivalence trial
  • Receipt of a $1.0 million, non-refundable option fee relating to negotiation of a potential future license of bremelanotide in a defined territory outside North America
  • Pivotal Phase 3 clinical trials anticipated to start in the first quarter of calendar year 2014

    • The Company obtained patents during the quarter:

  • U.S. Patent 8,487,073, entitled "Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction" issued July 16, 2013, claiming composition of matter on novel peptides for treatment of sexual dysfunction, obesity and related indications
  • U.S. Patent No. 8,492,517, entitled "Melanocortin-1 Receptor-Specific Cyclic Peptides" issued July 23, 2013, claiming composition of matter of lead peptides for treatment of inflammation-related diseases

    • First Quarter Fiscal 2014 Financial Results
    Palatin reported a net loss of $4.5 million, or $(0.04) per basic and diluted share, for the quarter ended September 30, 2013, compared to a net loss of $10.5 million, or $(0.15) per basic and diluted share, for the same period in 2012.The decrease in net loss for the quarter ended September 30, 2013 compared to the same period last fiscal year was mainly attributable to the recognition of a $7.1 million, non-operating expense, in the quarter ended September 30, 2012, which represented the increase in fair value of warrants issued in connection with Palatin'
    '/>"/>

    SOURCE Palatin Technologies, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
    2. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
    3. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
    4. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
    5. Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
    6. Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
    7. Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
    8. Palatin Technologies Announces Option for License to Bremelanotide in Europe
    9. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
    10. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
    11. Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) today announced ... of 2013 on Monday, February 3, 2014. A press release ... of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... operating highlights and financial results for the fourth quarter and ...
    (Date:1/14/2014)... 14, 2014 Dynamic Healthcare Services, Inc. ("DHS"), a portfolio ... acquired Progressive Home Medical Equipment, Inc. ("Progressive") of ... of the acquisition were not disclosed. Progressive ... a wide range of sleep, mobility, and respiratory products to ...
    (Date:1/14/2014)... 2014   NuAire , a manufacturer of ergonomically designed laboratory ... Koki of Japan to sell and ... . NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and ...
    Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
    (Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
    (Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
    (Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
    (Date:4/17/2014)... (April 17, 2014) Doctors who treat patients ... lymphangioleiomyomatosis (LAM) can face an agonizing treatment decision. ... the disease and help relieve shortness of breath. ... and sirolimus can cause potentially fatal complications following ... Dr. Daniel Dilling, medical director of Loyola University ...
    (Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
    Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
    ... experts say , SUNDAY, Dec. 27 (HealthDay News) -- ... infants on human milk, relatively few continue breast-feeding for ... an entire year. , Why not stick it ... moms, but California researchers say they found that returning ...
    ... cardiovascular disease, diabetes, study found , FRIDAY, Dec. 25 ... between having heavy sons and cardiovascular death, but having underweight ... Previous research has already linked obesity to higher rates of ... Studies have also shown that very thin people may be ...
    ... , , BOULDER, Colo., Dec. 25 ... : LULULEMON AD IN YOGA JOURNAL MAGAZINE: EFFECTIVE ADVERTISING , Lululemon, the ... of the park. It,s the kind of ad that earns its maker ... see the ad, featuring a disabled yogini, visit elephantjournal.com: , ...
    ... ... together nanotechnology to focus on Sports injury prevention and training , ... Mission Viejo, Calif. (PRWEB) December 25, ... first subsidiary for sports based technologies called MVP Sports Technologies, Inc., , ,MVP Sports ...
    ... depending on how product is designed, study shows , ... blamed for everything from promoting youth violence to contributing to ... parents who planned on passing by the video game aisle ... video games can sharpen certain thinking skills, increasing cognitive speed ...
    ... Today,s passage of health care reform in the U.S. Senate ... a promise we will make to every person living in this ... will be able to afford coverage and insurance companies will not ... other steps will include final passage after conference committee, effective implementation ...
    Cached Medicine News:Health News:Many Women Quit Breast-Feeding Early 2Health News:Many Women Quit Breast-Feeding Early 3Health News:Waylon Lewis of elephantjournal.com: Lululemon Ad; Naropa University Budget 2Health News:Applied Technology Holdings, Inc. Forms First New Subsidiary Called MVP Sports Technologies, Inc. 2Health News:Video Games Could Boost Certain Thinking Skills 2Health News:Video Games Could Boost Certain Thinking Skills 3Health News:A Promise to Keep. Senate Vote is the First Step Toward the Promise of Quality, Affordable Health Care for All 2
    0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
    ... SURPASS Perfusion Catheter is indicated ... stenotic portion of a coronary ... for the purpose of improving ... Catheters are also designed to ...
    16mm from Mid-screw to Tips, blunt tips; overall length 110mm; Stainless Steel...
    16mm from Mid-Screw to Blunt Tips, Gently Curved Blades; overall length 120mm; Stainless Steel...
    Medicine Products: